Sign In
Buy YTEN
$0.510
+0 (+0%)
At Close: Mar 05, 2025
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference
01:30pm, Thursday, 02'nd Dec 2021 Intrado Digital Media
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the Canola Week 2021 Conference taking place in virtual format November 30 through December 2, 2021.
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will presen
Zacks Investment Research Upgrades Yield10 Bioscience (NASDAQ:YTEN) to Buy
11:26am, Friday, 19'th Nov 2021 Dakota Financial News
Yield10 Bioscience (NASDAQ:YTEN) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research report issued on Friday, Zacks.com reports. The firm presently has a $6.00 price target on the specialty chemicals companys stock. Zacks Investment Researchs target price would suggest a potential upside of 21.70% from the stocks []
Yield10 Bioscience, Inc. (YTEN) CEO Ollie Peoples on Q3 2021 Results - Earnings Call Transcript
12:11am, Thursday, 11'th Nov 2021
Yield10 Bioscience, Inc. (YTEN) CEO Ollie Peoples on Q3 2021 Results - Earnings Call Transcript
Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates
06:19pm, Wednesday, 10'th Nov 2021
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of 22.22% and -57.99%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Yield10 Bioscience to Announce Third Quarter 2021 Financial Results and Host a Conference Call on Wednesday, November 10, 2021
08:30am, Wednesday, 03'rd Nov 2021
WOBURN, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its third quarter 2021 financi
Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference
08:30am, Thursday, 07'th Oct 2021
WOBURN, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will present
Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08:30am, Thursday, 09'th Sep 2021
WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a
Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2021 Results - Earnings Call Transcript
09:16pm, Wednesday, 11'th Aug 2021
Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2021 Results - Earnings Call Transcript
Metabolix, Inc. (YTEN) Reports Q2 Loss, Lags Revenue Estimates
07:23pm, Wednesday, 11'th Aug 2021
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -20.75% and -17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Yield10 Bioscience Announces Second Quarter 2021 Financial Results
04:02pm, Wednesday, 11'th Aug 2021
Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review
Will Metabolix, Inc. (YTEN) Report Negative Q2 Earnings? What You Should Know
04:47pm, Tuesday, 03'rd Aug 2021
Metabolix, Inc. (YTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yield10 Bioscience to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Wednesday, August 11, 2021
08:30am, Tuesday, 03'rd Aug 2021
WOBURN, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its second quarter 2021 financ
Yield10 Bioscience Announces Two New Hires as Camelina Business Plan Advances
08:30am, Tuesday, 29'th Jun 2021
—Dr. Munyikwa Appointed as Director of Regulatory Affairs—
WOBURN, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will presen
